Publication | Closed Access
Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma.
31
Citations
13
References
1997
Year
MIBI SPECT could be used as a screening test in predicting response to therapy in patients with NPC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1